Indicators

Latest News about FDMT

Recent news which mentions FDMT

< Previous 1 2 3 Next >

Forecasting The Future: 7 Analyst Projections For 4D Molecular Therapeutics

March 03, 2025

Eye Disease Focused 4D Molecular Therapeutics Lays Out 52-Week Results From Wet AMD Study

February 10, 2025

A Glimpse Into The Expert Outlook On 4D Molecular Therapeutics Through 9 Analysts

February 10, 2025

A Glimpse Into The Expert Outlook On 4D Molecular Therapeutics Through 6 Analysts

January 13, 2025

What 5 Analyst Ratings Have To Say About 4D Molecular Therapeutics

December 18, 2024

Amazon To Rally Around 21%? Here Are 10 Top Analyst Forecasts For Wednesday

December 18, 2024

Analyst Expectations For 4D Molecular Therapeutics's Future

November 14, 2024

4D Molecular Therapeutics Stock Falls After Follow-Up Data From Mid-Stage Study Of Vision Loss Drug Candidate

September 19, 2024

The Latest Analyst Ratings For 4D Molecular Therapeutics

September 09, 2024

FDMT Stock Earnings: 4D Molecular Therapeutics Beats EPS for Q2 2024

August 09, 2024

Why Domino's Pizza Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

July 18, 2024

Peeling Back The Layers: Exploring 4D Molecular Therapeutics Through Analyst Insights

July 18, 2024

4D Molecular Therapeutics Goes Neck To Neck With Rival, Shares New Phase 2 Data For Its Wet AMD Candidate

July 17, 2024

Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

July 17, 2024

Assessing 4D Molecular Therapeutics: Insights From 7 Financial Analysts

June 26, 2024

Goldman Sachs Optimistic About Regenxbio's Gene Therapy Pipeline, Sees Over 160% Upside

June 07, 2024

Analyst Expectations For 4D Molecular Therapeutics's Future

June 07, 2024

Why G-III Apparel Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

June 06, 2024

Why Is 4D Molecular Therapeutics Stock Trading Lower On Thursday? Genetic Disease-Focused Study Data Released

June 06, 2024

12 Health Care Stocks Moving In Thursday's Intraday Session

June 06, 2024

FDMT Stock Earnings: 4D Molecular Therapeutics Beats EPS, Misses Revenue for Q1 2024

May 09, 2024

To The Moon! A Look Inside An ETF Focused On Companies At The Cutting Edge Of Innovation

April 18, 2024

4D Molecular Therapeutics Outlines Pivotal Development Plans For Cystic Fibrosis, Rare Inherited Disease

March 28, 2024

4D Molecular Therapeutics Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)

March 01, 2024

Why Is Blindness Focused-Adverum Biotechnologies Stock Trading Lower Today?

February 08, 2024

Why 4D Molecular Therapeutics (FDMT) Stock Is Diving

February 07, 2024

What 4 Analyst Ratings Have To Say About 4D Molecular Therapeutics

February 07, 2024

4D Molecular Therapeutics' 4D-150 Phase 2 Data Met Investor Expectations, Analyst Boosts Forecast

February 06, 2024

Why Is 4D Molecular (FDMT) Stock Up 85% Today?

February 05, 2024

Crude Oil Moves Higher; Caterpillar Posts Upbeat Earnings

February 05, 2024

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.